KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Non-Current Deferred Tax Liability (2016 - 2026)

Chemed filings provide 18 years of Non-Current Deferred Tax Liability readings, the most recent being $14.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 23.82% year-over-year to $14.6 million, compared with a TTM value of $14.6 million through Mar 2026, up 23.82%, and an annual FY2025 reading of $19.3 million, down 25.56% over the prior year.
  • Non-Current Deferred Tax Liability hit $14.6 million in Q1 2026 for Chemed, down from $19.3 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $38.6 million in Q4 2022, with the low at $9.7 million in Q3 2025.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $25.9 million (2024), compared with a mean of $24.7 million.
  • The sharpest move saw Non-Current Deferred Tax Liability surged 85.09% in 2023, then tumbled 65.5% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $38.6 million in 2022, then fell by 21.47% to $30.3 million in 2023, then fell by 14.43% to $25.9 million in 2024, then dropped by 25.56% to $19.3 million in 2025, then fell by 24.53% to $14.6 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $14.6 million, $19.3 million, and $9.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.